Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

European Commission Consults On GMP For Authorized Medicines

This article was originally published in SRA

Executive Summary

A fourth consultation document, on proposed new good manufacturing practice (GMP) rules for medicines with a marketing authorization, has been launched by the European Commission as part of its drive to implement the provisions of the Clinical Trials Regulation1.